Priorities far beyond generating morbidity or mortality data are needed to improve patients’ experiences, innovate metrics, and advance surgical palliation as a field.
AMA J Ethics. 2021;23(10):E806-810. doi:
10.1001/amajethics.2021.806.
Distinctions between treatment and enhancement, and between supposedly authentic and inauthentic tools, often inform judgments about what is morally acceptable in sport.
The differences between CBPR and traditional research have been enumerated, but how to overcome them is still up for discussion, collaboration with community members is advocated, and examples are given.
VCA candidates need clinicians to help them become familiar with experimental surgery eligibility criteria, prior and possible outcomes, and potential risks and benefits.
AMA J Ethics. 2019;21(11):E960-967. doi:
10.1001/amajethics.2019.960.